(NYSE: STE) Steris's forecast annual revenue growth rate of 5.75% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.09%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.75%.
Steris's revenue in 2024 is $5,138,701,000.On average, 3 Wall Street analysts forecast STE's revenue for 2025 to be $542,238,689,227, with the lowest STE revenue forecast at $539,722,969,673, and the highest STE revenue forecast at $543,584,124,963. On average, 3 Wall Street analysts forecast STE's revenue for 2026 to be $572,563,509,193, with the lowest STE revenue forecast at $569,505,125,284, and the highest STE revenue forecast at $577,951,878,438.
In 2027, STE is forecast to generate $600,499,102,718 in revenue, with the lowest revenue forecast at $600,496,135,718 and the highest revenue forecast at $600,502,168,618.